ADMISSION is a new Research Collaborative funded by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) that brings together scientists, clinicians and patients from five UK universities and hospitals (Newcastle, Birmingham, Manchester Metropolitan, University College London and Dundee) to transform understanding of multiple long-term conditions in hospital patients.
Living with multiple long-term conditions, also known as multimorbidity, is very common among people admitted to hospital. These patients often stay in hospital for longer and their recovery may be slower. However, the way that care is delivered in hospital is not ideal; in a system that was designed for the treatment of single conditions, the care of patients with multimorbidity can be unsatisfactory, inefficient and costly. To date there has been little research on multimorbidity in hospital patients, which is crucial to understand how services need to be changed.
Harnessing the power of ‘big data’ from routinely-collected hospital, primary and social care records, along with research studies such as UK Biobank and the Scottish Health Research Register (SHARE), ADMISSION will include cutting-edge data science, use of novel computing and statistical techniques, care pathway analysis, qualitative methods and genetic epidemiology. It will take a systematic approach to characterising multiple long-term conditions in hospital patients, focusing on burden and the occurrence of inequalities, describing the links to care pathways and investigating the underlying biological causes.
ADMISSION will lay foundations for new approaches to the recognition and treatment of multimorbidity in hospital and inform the design of future care, with potential to improve health outcomes for the millions of patients with multimorbidity admitted to hospital each year.
Please follow us on Twitter for the latest updates @AdmissionCollab
For further information on the funding award and UKRI Multimorbidity/multiple long-term conditions initiative please click here.